HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An Open Trial of Lurasidone as an Acute and Maintenance Adjunctive Treatment for Outpatients With Treatment-Resistant Bipolar Disorder.

AuthorsCharles B Schaffer, Linda C Schaffer, Thomas E Nordahl, Nicole M Stark, Caroline E Gohring
JournalJournal of clinical psychopharmacology (J Clin Psychopharmacol) Vol. 36 Issue 1 Pg. 88-9 (Feb 2016) ISSN: 1533-712X [Electronic] United States
PMID26650972 (Publication Type: Letter)
Chemical References
  • Antipsychotic Agents
  • Lurasidone Hydrochloride
Topics
  • Adult
  • Aged
  • Antipsychotic Agents (administration & dosage, therapeutic use)
  • Bipolar Disorder (drug therapy)
  • Depressive Disorder, Treatment-Resistant (drug therapy)
  • Female
  • Humans
  • Lurasidone Hydrochloride (administration & dosage, therapeutic use)
  • Male
  • Middle Aged
  • Outpatients
  • Retrospective Studies
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: